Detrol and Respiratory disorder for Women aged 60+ (a phase IV clinical study of FDA data)
Summary:
Respiratory disorder is found for women aged 60+ who take Detrol (tolterodine tartrate). This study is created by eHealthMe based on reports of 8,358 women aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Detrol when people have Respiratory disorder
- Top conditions
- Top co-used drugs
- Top other side effects
8,358 women aged 60+ reported to have side effects when taking Detrol.
Among them, 17 people (0.2%) have Respiratory disorder
What is Detrol?
Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.
What is Respiratory disorder?
Respiratory disorder (respiratory disease) is found to be associated with 1,542 drugs and 1,582 conditions by eHealthMe. Check the latest studies of Respiratory disorder.
Number of reports submitted per year:

Time on Detrol when people have Respiratory disorder *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Severity of Respiratory disorder
n/aHow people recovered from Respiratory disorder
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- High Blood Pressure: 4 people, 23.53%
- Asthma: 3 people, 17.65%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 17.65%
- Bladder Disorder: 3 people, 17.65%
- High Blood Cholesterol: 2 people, 11.76%
- Type 2 Diabetes: 1 person, 5.88%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 5.88%
- Cough: 1 person, 5.88%
- Diarrhea: 1 person, 5.88%
- Dyspnea (difficult or laboured breathing): 1 person, 5.88%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Lipitor: 6 people, 35.29%
- Synthroid: 4 people, 23.53%
- Singulair: 4 people, 23.53%
- Vasotec: 4 people, 23.53%
- Folic Acid: 3 people, 17.65%
- Norvasc: 3 people, 17.65%
- Enbrel: 3 people, 17.65%
- Pantoprazole Sodium: 3 people, 17.65%
- Plaquenil: 3 people, 17.65%
- Celebrex: 3 people, 17.65%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Headache (pain in head): 7 people, 41.18%
- Dyspnea (difficult or laboured breathing): 5 people, 29.41%
- Chest Pain: 5 people, 29.41%
- Pneumonia: 4 people, 23.53%
- Drug Ineffective: 4 people, 23.53%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 23.53%
- Respiratory Distress (difficulty in breathing): 4 people, 23.53%
- Asthma: 4 people, 23.53%
- Oxygen Saturation Decreased: 3 people, 17.65%
- Malaise (a feeling of general discomfort or uneasiness): 3 people, 17.65%
* Approximation only. Some reports may have incomplete information.
Do you take Detrol and have Respiratory disorder?
- Check whether Respiratory disorder is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, tolterodine tartrate (the active ingredients of Detrol) and Detrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rituxan and Inconsolability for Women aged 60+ - now
- Could Lopressor cause Angiodysplasia? - now
- Could Lipitor cause Parotid Gland Enlargement? - 7 seconds ago
- Requip and Pneumonia for Men aged 60+ - 7 seconds ago
- Requip and Pneumonitis for Men aged 60+ - 8 seconds ago
- Requip and Bronchopneumonia for Men aged 60+ - 8 seconds ago
- Heparin and Thiamine drug interactions for men aged 30-39 - 8 seconds ago
- Requip and Community-Acquired Pneumonia for Men aged 60+ - 8 seconds ago
- Indapamide and Rosuvastatin Calcium drug interactions for men aged 40-49 - 15 seconds ago
- Escitalopram and Tonsillar Ulcer for Women aged 40-49 - 16 seconds ago